The expression of NKp30 (56.57%) and NKp46 (54.2%) on NK cells was elevated in ALL subjects at diagnosis as compared to healthy subjects (46.1% and 49.9%, respectively), which further reduced after induction chemotherapy (45.1% and 43.9%, respectively; Figure 5d,e). The gene discussed is NCR1; the disease is acute lymphoblastic leukemia.